Literature DB >> 9174050

Altered expression of Erg and Ets-2 transcription factors is associated with genetic changes at 21q22.2-22.3 in immortal and cervical carcinoma cell lines.

S Simpson1, C D Woodworth, J A DiPaolo.   

Abstract

Human Papillomavirus (HPV) type 16 is the most frequently detected HPV in cervical cancer. Although epidemiologic and experimental evidence indicates a prominent role for HPV infection in the development of this disease, other factors are also involved. Altered expression of the ets family transcription factors erg and ets-2 was found associated with the development of cervical carcinoma. Overexpression also occurred in a HPV-16-immortalized cervical cell line, CX16-2, which has HPV integrated at a translocation breakpoint t(19;21) involving 21q22.2-22.3, where these genes have been mapped. Six of 10 cervical carcinoma cell lines overexpressed ets-2 RNA suggesting an association of overexpression with cervical cell neoplasia. A clonally related pair of cervical carcinoma cell lines, C-4I and C-4II, showed differential expression of erg and ets-2. C-4I overexpressed ets-2 RNA compared to normal cervical cells and C-4II. C-4II expressed a 5.3 kb erg transcript not seen in C-4I, ectocervical cells or other cervical carcinoma cell lines examined. Pulsed field gel electrophoresis was used to analyse changes in DNA fragments related to structural changes and to construct a physical map encompassing erg and ets-2. Alterations in erg and ets-2 RNA expression in each of three different cell lines examined were associated with translocations. Association between altered expression of erg and ets-2 and altered regional structural suggests that these genes are important targets in cervical carcinogenesis.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9174050     DOI: 10.1038/sj.onc.1201058

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  9 in total

1.  ERG transcription factor as an immunohistochemical marker for vascular endothelial tumors and prostatic carcinoma.

Authors:  Markku Miettinen; Zeng-Feng Wang; Anders Paetau; Shyh-Han Tan; Albert Dobi; Shiv Srivastava; Isabell Sesterhenn
Journal:  Am J Surg Pathol       Date:  2011-03       Impact factor: 6.394

2.  The clinical role of the PEA3 transcription factor in ovarian and breast carcinoma in effusions.

Authors:  Ben Davidson; Iris Goldberg; Liora Tell; Sophya Vigdorchik; Mark Baekelandt; Aasmund Berner; Gunnar B Kristensen; Reuven Reich; Juri Kopolovic
Journal:  Clin Exp Metastasis       Date:  2004       Impact factor: 5.150

3.  Modulation of androgen receptor signaling in hormonal therapy-resistant prostate cancer cell lines.

Authors:  Rute B Marques; Natasja F Dits; Sigrun Erkens-Schulze; Wilfred F J van Ijcken; Wytske M van Weerden; Guido Jenster
Journal:  PLoS One       Date:  2011-08-04       Impact factor: 3.240

4.  Ets2 knockdown inhibits tumorigenesis in esophageal squamous cell carcinoma in vivo and in vitro.

Authors:  Qinghua Li; Lu Yang; Kang Han; Liqiang Zhu; Yanting Zhang; Shanshan Ma; Kun Zhang; Bo Yang; Fangxia Guan
Journal:  Oncotarget       Date:  2016-09-20

5.  Association of Long Non-Coding RNAs (lncRNAs) ANRIL and MALAT1 Polymorphism with Cervical Cancer.

Authors:  Yueting Yao; Yan Liang; Xudong Dong; Shuyuan Liu; Shao Zhang; Weipeng Liu; Yu Li; Li Shi; Zhiling Yan; Yufeng Yao
Journal:  Pharmgenomics Pers Med       Date:  2022-04-21

6.  EGR1 promotes stemness and predicts a poor outcome of uterine cervical cancer by inducing SOX9 expression.

Authors:  Juanhong Zhao; Haixia Li; Miao Yuan
Journal:  Genes Genomics       Date:  2021-03-09       Impact factor: 1.839

7.  The function of APC/CCdh1 in cell cycle and beyond.

Authors:  Min Li; Pumin Zhang
Journal:  Cell Div       Date:  2009-01-19       Impact factor: 5.130

8.  An Optimization-Driven Analysis Pipeline to Uncover Biomarkers and Signaling Paths: Cervix Cancer.

Authors:  Enery Lorenzo; Katia Camacho-Caceres; Alexander J Ropelewski; Juan Rosas; Michael Ortiz-Mojer; Lynn Perez-Marty; Juan Irizarry; Valerie Gonzalez; Jesús A Rodríguez; Mauricio Cabrera-Rios; Clara Isaza
Journal:  Microarrays (Basel)       Date:  2015-06

Review 9.  Cyclin-Dependent Kinases (CDK) and Their Role in Diseases Development-Review.

Authors:  Paweł Łukasik; Michał Załuski; Izabela Gutowska
Journal:  Int J Mol Sci       Date:  2021-03-13       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.